8ALP
Botulinum neurotoxin A6 cell binding domain crystal form II
This is a non-PDB format compatible entry.
Experimental procedure
| Experimental method | SINGLE WAVELENGTH |
| Source type | SYNCHROTRON |
| Source details | DIAMOND BEAMLINE I04 |
| Synchrotron site | Diamond |
| Beamline | I04 |
| Temperature [K] | 100 |
| Detector technology | PIXEL |
| Collection date | 2021-10-16 |
| Detector | DECTRIS EIGER2 XE 16M |
| Wavelength(s) | 0.9795 |
| Spacegroup name | P 21 21 21 |
| Unit cell lengths | 39.554, 78.938, 118.550 |
| Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
| Resolution | 65.705 - 1.500 |
| Rwork | 0.248 |
| R-free | 0.28930 |
| Structure solution method | MOLECULAR REPLACEMENT |
| Starting model (for MR) | 6two |
| RMSD bond length | 0.010 |
| RMSD bond angle | 1.547 |
| Data reduction software | DIALS |
| Data scaling software | Aimless |
| Phasing software | PHASER |
| Refinement software | REFMAC (5.8.0267) |
Data quality characteristics
| Overall | Outer shell | |
| Low resolution limit [Å] | 118.550 | 1.530 |
| High resolution limit [Å] | 1.500 | 1.500 |
| Rmerge | 0.119 | 5.680 |
| Rpim | 0.023 | 1.125 |
| Number of reflections | 60147 | 2894 |
| <I/σ(I)> | 12 | 0.7 |
| Completeness [%] | 99.6 | 97.5 |
| Redundancy | 26.3 | |
| CC(1/2) | 1.000 | 0.330 |
Crystallization Conditions
| crystal ID | method | pH | temperature | details |
| 1 | VAPOR DIFFUSION, SITTING DROP | 289.15 | 0.1 M magnesium acetate tetrahydrate, 0.1 M MES pH 6.5, 12% w/v of 50% PEG smear medium (4.55% v/v PEG 400, 4.55% v/v PEG 500 MME, 4.55% v/v PEG 600, 4.55% w/v PEG 1000, 4.55% w/v PEG 2000, 4.55% w/v PEG 3350, 4.55% w/v PEG 4000, 4.55% w/v PEG 5000 MME, 4.55% w/v PEG 6000, 4.55% w/v PEG 8000, 4.55% w/v PEG 10000) |






